Antimicrobial stewardship programs in health care systems

被引:483
作者
MacDougall, C
Polk, RE
机构
[1] Univ Calif San Francisco, Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA
[2] Virginia Commonwealth Univ, Sch Pharm, Dept Pharm, Richmond, VA 23298 USA
关键词
D O I
10.1128/CMR.18.4.638-656.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Antimicrobial stewardship programs in hospitals seek to optimize antimicrobial prescribing in order to improve individual patient care as well as reduce hospital costs and slow the spread of antimicrobial resistance. With antimicrobial resistance on the rise worldwide and few new agents in development, antimicrobial stewardship programs are more important than ever in ensuring the continued efficacy of available antimicrobials. The design of antimicrobial management programs should be based on the best current understanding of the relationship between antimicrobial use and resistance. Such programs should be administered by multidisciplinary teams composed of infectious diseases physicians, clinical pharmacists, clinical microbiologists, and infection control practitioners and should be actively supported by hospital administrators. Strategies for changing antimicrobial prescribing behavior include education of prescribers regarding proper antimicrobial usage, creation of an antimicrobial formulary with restricted prescribing of targeted agents, and review of antimicrobial prescribing with feedback to prescribers. Clinical computer systems can aid in the implementation of each of these strategies, especially as expert systems able to provide patient-specific data and suggestions at the point of care. Antibiotic rotation strategies control the prescribing process by scheduled changes of antimicrobial classes used for empirical therapy. When instituting an antimicrobial stewardship program, a hospital should tailor its choice of strategies to its needs and available resources.
引用
收藏
页码:638 / +
页数:20
相关论文
共 164 条
[11]   Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults [J].
Bauer, TH ;
Lalvani, A ;
Fehrenbach, J ;
Steffen, I ;
Aponte, JJ ;
Segovia, R ;
Vila, J ;
Philippczik, G ;
Steinbrückner, B ;
Frei, R ;
Bowler, I ;
Kist, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (03) :313-319
[12]   Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia [J].
Beezhold, DW ;
Slaughter, S ;
Hayden, MK ;
Matushek, M ;
Nathan, C ;
Trenholme, GM ;
Weinstein, RA .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) :704-706
[13]   Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals [J].
Bergstrom, CT ;
Lo, M ;
Lipsitch, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (36) :13285-13290
[14]   Benchmarking in health-system pharmacy: Current research and practical applications [J].
Bhavnani, SM .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (20) :S13-S20
[15]   Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United States [J].
Bhavnani, SM ;
Hammel, JP ;
Jones, RN ;
Ambrose, PG .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 51 (01) :31-37
[16]   Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin [J].
Bisognano, C ;
Vaudaux, P ;
Rohner, P ;
Lew, DP ;
Hooper, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1428-1437
[17]   Evaluating treatment protocols to prevent antibiotic resistance [J].
Bonhoeffer, S ;
Lipsitch, M ;
Levin, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (22) :12106-12111
[18]   Understanding the spread of antibiotic resistant pathogens in hospitals: Mathematical models as tools for control [J].
Bonten, MJM ;
Austin, DJ ;
Lipsitch, M .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (10) :1739-1746
[19]   Do infection control measures work for methicillin-resistant Staphylococcus aureus? [J].
Boyce, JM ;
Havill, NL ;
Kohan, C ;
Dumigan, DG ;
Ligi, CE .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2004, 25 (05) :395-401
[20]   EPIDEMIOLOGIC ANALYSIS AND GENOTYPIC CHARACTERIZATION OF A NOSOCOMIAL OUTBREAK OF VANCOMYCIN-RESISTANT ENTEROCOCCI [J].
BOYLE, JF ;
SOUMAKIS, SA ;
RENDO, A ;
HERRINGTON, JA ;
GIANARKIS, DG ;
THURBERG, BE ;
PAINTER, BG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (05) :1280-1285